Virtu Financial’s BioTelemetry, Inc. BEAT Stock Holding History

Virtu Financial’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,875	Closed	-$568K	–	2374
2020 Q4	$568K	Buy	+7,875	New	+$412K	0.06%	401
2020 Q3	–	Sell	-17,773	Closed	-$803K	–	1816
2020 Q2	$803K	Buy	+17,773	New	+$796K	0.09%	244
2019 Q4	$229K	Buy	+4,937	New	+$214K	0.02%	843
2019 Q3	–	Sell	-4,150	Closed	-$200K	–	2076
2019 Q2	$200K	Buy	+4,150	New	+$218K	0.01%	1025

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Virtu Financial's BEAT Position: Q1 2021 in Review

Virtu Financial sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 7,875 shares — an estimated $568K sold.

Virtu Financial first reported a position in BEAT in Q2 2019 and held it in 4 quarters. The position peaked at $803K in Q2 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Virtu Financial reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Virtu Financial sold 7,875 BioTelemetry, Inc. shares in Q1 2021, an estimated $568K.
Virtu Financial first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 4 quarters.
Virtu Financial's BioTelemetry, Inc. position peaked at $803K in Q2 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Virtu Financial's 13F filing for Q1 2021, filed 19 May 2021.